|
|
Volumn 324, Issue 5934, 2009, Pages 1504-1507
|
|
The promise of a cure: 20 years and counting
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NEW DRUG;
TRANSMEMBRANE CONDUCTANCE REGULATOR;
UNCLASSIFIED DRUG;
VX 770;
VX 809;
DISEASE CONTROL;
GENE;
GENETIC ENGINEERING;
CLINICAL RESEARCH;
CLINICAL TRIAL;
CYSTIC FIBROSIS;
DISEASE MODEL;
DRUG TREATMENT FAILURE;
FUNDING;
GENE EXPRESSION PROFILING;
GENE IDENTIFICATION;
GENE MUTATION;
GENE REPLACEMENT THERAPY;
GENE TARGETING;
GENE THERAPY;
GENETIC ASSOCIATION;
GENETIC TRANSFECTION;
GENOTYPE ENVIRONMENT INTERACTION;
HUMAN;
INVESTMENT;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
ADULT;
ANIMAL;
GENETICS;
HISTORY;
MALE;
NOTE;
PRESCHOOL CHILD;
ADULT;
ANIMALS;
CHILD, PRESCHOOL;
CYSTIC FIBROSIS;
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;
GENE THERAPY;
HISTORY, 20TH CENTURY;
HISTORY, 21ST CENTURY;
HUMANS;
MALE;
|
|
EID: 67649228313
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.324_1504 Document Type: Short Survey |
|
Times cited : (30)
|
|
References (0)
|